Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic-pituitary-adrenal axis and other consequences of daily repeated stress

European Neuropsychopharmacology

Volumn 25, Issue 8, 2015, Pages 1248-1259

  Rabasa, Cristina ^a,c,d   Pastor Ciurana, Jordi ^a,c   Delgado Morales, Raúl ^a,c,e   Gómez Román, Almudena ^a,c   Carrasco, Javier ^a,c   Gagliano, Humberto ^a,c   García Gutiérrez, María S ^b,c   Manzanares, Jorge ^b,c   Armario, Antonio ^a,c  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c RETICS Red Temática de Investigación Cooperativa Sanitaria en Enfermedades Oculares Oftared   (Spain)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

AM251; Cannabinoids; Chronic stress; Habituation

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; CANNABINOID RECEPTOR ANTAGONIST; CNR1 PROTEIN, MOUSE; CNR1 PROTEIN, RAT; CORTICOSTERONE; GLUCOSE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; CD-1 MOUSE; CONTROLLED STUDY; EXPERIMENTAL DESIGN; FORCED SWIM TEST; GENE EXPRESSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; KNOCKOUT MOUSE; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; THYMUS; WEIGHT GAIN; WILD TYPE MOUSE; ADAPTIVE BEHAVIOR; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BODY WEIGHT; DISEASE MODEL; DRUG EFFECTS; EXERCISE; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL STRESS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SWIMMING;

ADAPTATION, PSYCHOLOGICAL; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BODY WEIGHT; CANNABINOID RECEPTOR ANTAGONISTS; CORTICOSTERONE; DISEASE MODELS, ANIMAL; GLUCOSE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE, KNOCKOUT; PIPERIDINES; PITUITARY-ADRENAL SYSTEM; PYRAZOLES; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84938745736     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.04.026     Document Type: Article

References (49)

1. Aliczki M., Zelena D., Mikics E., Varga Z.K., Pinter O., Bakos N.V., Varga J., Haller J. Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity n male CD1 mice. Horm. Behav. 2013, 63:752-758.
2. Amador-Arjona A., Delgado-Morales R., Belda X., Gagliano H., Gallego X., Keck M.E., Armario A., Dierssen M. Susceptibility to stress in transgenic mice overexpressing TrkC, a model of panic disorder. J. Psychiatry Res. 2010, 44:157-167.
3. Armario A., Castellanos J.M., Balasch J. Effect of acute and chronic psychogenic stress on corticoadrenal and pituitary-thyroid hormones in male rats. Horm. Res. 1984, 20:241-245.
4. Armario A. Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol. Sci. 2010, 31:318-325.
5. Armario A., Daviu N., Muñoz-Abellán C., Rabasa C., Fuentes S., Belda X., Gagliano H., Nadal R. What can we know from pituitary-adrenal hormones about the nature and consequences of exposure to emotional stressors?. Cell. Mol. Neurobiol. 2012, 32:749-758.
6. Aso E., Ozaita A., Valdizan E.M., Ledent C., Pazos A., Maldonado R., Valverde O. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J. Neurochem. 2008, 105:565-572.
7. Atkinson H.C., Leggett J.D., Wood S.A., Castrique E.S., Kershaw Y.M., Lightman S.L. Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic. Endocrinology 2010, 151:3720-3727.
8. Bedse G., Colangeli R., Lavecchia A.M., Romano A., Altieri F., Cifani C., Cassano T., Gaetani S. Role of the basolateral amígdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress. Eur. Neuropsychopharmacol. 2014, 24:1511-1523.
9. Campeau S., Dolan D., Akil H., Watson S.J. C-fos mRNA induction after acute and chronic audiogenic stress: possible role of the orbitofrontal cortex in habituation. Stress 2002, 5:121-130.
10. Campos A.C., Ferreira F.R., Guimaraes F.S., Lemos J.I. Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. Neuroscience 2010, 167:238-246.
11. Cota D., Marsicano G., Tschop M., Grubler Y., Flachskamm C., Schubert M., Auer D., Yassouridis A., Thone-Reineke C., Ortmann S., Tomassoni F., Cervino C., Nisoli E., Linthorst A.C., Pasquali R., Lutz B., Stalla G.K., Pagotto U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 2003, 112:423-431.
12. Cota D., Steiner M.A., Marsicano G., Cervino C., Herman J.P., Grubler Y., Stalla J., Pasquali R., Lutz B., Stalla G.K., Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 2007, 148:1574-1581.
13. Di S., Malcher-Lopes R., Halmos K.C., Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 2003, 23:4850-4857.
14. Engeland W.C., Miller P., Gann D.S. Dissociation between changes in plasma bioactive and immunoreactiveadrenocorticotropin after hemorrhage in awake dogs. Endocrinology 1989, 124:2978-2985.
15. Evanson N.K., Tasker J.G., Hill M.N., Hillard C.J., Herman J.P. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 2010, 151:4811-4819.
16. Fride E., Suris R., Weidenfeld J., Mechoulam R. Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice. Behav. Pharmacol. 2005, 16:431-440.
17. Ganon-Elazar E., Akirav I. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J. Neurosci. 2009, 29:11078-11088.
18. Haller J., Varga B., Ledent C., Barna I., Freund T.F. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur. J. Neurosci. 2004, 19:1906-1912.
19. Hardin J.W., Hilbe J.M. Generalized Estimating Equations 2003, Chapman & Hall/CRC, Boca Raton.
20. Hartmann J., Wagner K.V., Dedic N., Marinescu D., Scharf S.H., Wang X.D., Deussing J.M., Müller M.B., Schmidt M.V. Fkbp52 heterozygosity alters behavioral, endocrine and neurogenetic parameters under basal and chronic stress conditions in mice. Psychoneuroendocrinology 2012, 37:2009-2021.
21. Hill M.N., McLaughlin R.J., Bingham B., Shrestha L., Lee T.T., Gray J.M., Hillard C.J., Gorzalka B.B., Viau V. Endogenous cannabinoid signaling is essential for stress adaptation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9406-9411.
22. Hill M.N., Hillard C.J., McEwen B.S. Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress. Cereb. Cortex 2011, 21:2056-2064.
23. Hill M.N., McLaughlin R.J., Pan B., Fitzgerald M.L., Roberts C.J., Lee T.T., Karatsoreos I.N., Mackie K., Viau V., Pickel V.M., McEwen B.S., Liu Q.S., Gorzalka B.B., Hillard C.J. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J. Neurosci. 2011, 31:10506-10515.
24. Hill M.N., Tasker J.G. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 2012, 204:5-16.
25. Hof P.R., Young W.G., Bloom F.E., Belichenko P.V., Celio M.R. Comparative Cytoarchitectonic Atlas of the C57BL6 and 129Sv Mouse Brains 2000, Elsevier, New York.
26. Kamprath K., Plendl W., Marsicano G., Deussing J.M., Wurst W., Lutz B., Wotjak C.T. Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling. Genes Brain Behav. 2009, 8:203-211.
27. Kiss A., Aguilera G. Regulation of the hypothalamic pituitary adrenal axis during chronic stress: responses to repeated intraperitoneal hypertonic saline injection. Brain Res. 1993, 630:262-270.
28. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999, 283:401-404.
29. Mamalaki E., Kvetnansky R., Brady L.S., Gold P.W., Herkenham M. Repeated immobilization stress alters tyrosine hydroxylase, corticotropin-releasing hormone and corticosteroid receptor messenger ribonucleic acid levels in rat brain. J. Neuroendocrinol. 1992, 4:689-699.
30. Manzanares J., Corchero J., Fuentes J.A. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats. Brain Res. 1999, 839:173-179.
31. Marquez C., Nadal R., Armario A. The hypothalamic-pituitary-adrenal and glucose responses to daily repeated immobilisation stress in rats: individual differences. Neuroscience 2004, 123:601-612.
32. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgansberger W., Di Marzo V., Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
33. Marti O., Armario A. Anterior pituitary response to stress: time-related changes and adaptation. Int. J. Dev. Neurosci. 1998, 16:241-260.
34. Marti O., Gavalda A., Jolin T., Armario A. Effect of regularity of exposure to chronic immobilization stress on the circadian pattern of pituitary adrenal hormones, growth hormone, and thyroid stimulating hormone in the adult male rat. Psychoneuroendocrinology 1993, 18:67-77.
35. McCulloch C.E., Searle S.R. Generalized, Linear, and Mixed Models 2001, John Wiley & Sons, New York.
36. Patel S., Hillard C.J. Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur. J. Neurosci. 2008, 27:2821-2829.
37. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145:5431-5438.
38. Patel S., Roelke C.T., Rademacher D.J., Hillard C.J. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur. J. Neurosci. 2005, 21:1057-1069.
39. Rabasa C., Delgado-Morales R., Munoz-Abellan C., Nadal R., Armario A. Adaptation of the hypothalamic-pituitary-adrenal axis and glucose to repeated immobilization or restraint stress is not influenced by associative signals. Behav. Brain Res. 2011, 217:232-239.
40. Rabasa C., Delgado-Morales R., Gómez-Román A., Nadal R., Armario A Adaptation of the pituitary-adrenal axis to daily repeated forced swim exposure in rats is dependent on the temperature of water. Stress 2013, 16:698-705.
41. Saber-Tehrani A., Naderi N., Hosseini Najarkolaei A., Haghparast A., Motamedi F. Cannabinoids and their interactions with diazepam on modulation of serum corticosterone concentration in male mice. Neurochem. Res. 2010, 35:60-66.
42. Schmidt M.V., Scharf S.H., Sterlemann V., Ganea K., Liebl C., Holsboer F., Müller M.B. High susceptibility to chronic social stress is associated with a depression-like phenotype. Psychoneuroendocrinology 2010, 35:635-643.
43. Steiner M.A., Marsicano G., Nestler E.J., Holsboer F., Lutz B., Wotjak C.T. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 2008, 33:54-67.
44. Steiner M.A., Wotjak C.T. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog. Brain Res. 2008, 170:397-432.
45. Uriguen L., Perez-Rial S., Ledent C., Palomo T., Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 2004, 46:966-973.
46. Veenema A.H., Meijer O.C., de Kloet E.R., Koolhaas J.M. Genetic selection for coping style predicts stressor susceptibility. J. Neuroendocrinol. 2003, 15:256-267.
47. Zelena D., Barna I., Mlynarik M., Gupta O.P., Jezova D., Makara G.B. Stress symptoms induced by repeated morphine withdrawal in comparison to other chronic stress models in mice. Neuroendocrinology 2005, 81:205-215.
48. Zelena D., Mergl Z., Foldes A., Kovacs K.J., Toth Z., Makara G.B. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint. Am. J. Physiol. Endocrinol. Metab. 2003, 285:1110-1117.
49. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:5780-5785.